search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Among IVF-ICSI patients with poor implantation, does PGS increase pregnancy rates and live birth rates?


- candidate number3463
- NTR NumberNTR1347
- ISRCTNISRCTN wordt niet meer aangevraagd
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR11-jun-2008
- Secondary IDs5 UZ Brussel
- Public TitleAmong IVF-ICSI patients with poor implantation, does PGS increase pregnancy rates and live birth rates?
- Scientific TitleAmong IVF-ICSI patients with poor implantation, does PGS increase pregnancy rates and live birth rates?
- ACRONYMPGS, recurrent implantation failure
- hypothesisThe hypothesis of the present study tries to elucidate the causes of multiple IVF failures in subfertile couples with repeated implantation failure.Therefore, these couples will undergo an IVF-cycle with or without PGS.
- Healt Condition(s) or Problem(s) studiedPregnancy, In vitro fertilization (IVF), Intracytoplasmic sperm injection (ICSI), Preimplantation genetic screening (PGS), Embryo implantation
- Inclusion criteria1. Subfertility with need for ART with motile sperm
2. Three or more failed IVF or ICSI attempts with embryos of good morphological quality
3. Maternal age less than 38 years
4. A normal karyotype in both partners.
- Exclusion criteria1. Maternal age above 38 years.
2. Presence of uterine pathology
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingNone
- controlPlacebo
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-nov-2001
- planned closingdate31-dec-2008
- Target number of participants200
- InterventionsIn both groups, patients underwent controlled ovarian hyperstimulation. IVF-ICSI was perfomed in every study patient. On day three of the embryonic development, preimplantation genetic diagnosis was performed on the embryos in the study group. The embryo transfer took place on day 5 of embryonic development.
- Primary outcomeThe primary outcome is the implantation rate, which is defined as the ratio between the number of gestational sacs with a fetal heartbeat and the total number of embryos transferred.
- Secondary outcomeSecondary endpoints are embryo morphology and chromosomal status, number of transferred embryos and clinical pregnancy rate.
- TimepointsDay of egg retrieval (ovum pick-up) (t=0)
Day of fertilisation (t=1)
Embryonic development and biopsy (t=3)
Day of embryo transfer (t=5)
Pregnancy outcome (t=35)
- Trial web siteN/A
- statusinclusion stopped: follow-up
- CONTACT FOR PUBLIC QUERIESDr. Christophe Blockeel
- CONTACT for SCIENTIFIC QUERIESDr. Christophe Blockeel
- Sponsor/Initiator Universitair Ziekenhuis Brussel (UZB), Centre for Reproductive Medicine
- Funding
(Source(s) of Monetary or Material Support)
Universitair Ziekenhuis Brussel (UZB), Centre for Reproductive Medicine
- PublicationsN/A
- Brief summaryObjective: To verify whether advantages con derive from the implementation of preimplantation genetic diagnosis for aneuploidy in patients with recurrent failed implantation, compared with conventional treatment procedures.

Design: A randomized, controlled trial.

Setting: Centre for Reproductive Medicine of the Universitair Ziekenhuis Brussel, Brussel, Belgium.

Patient(s): Two hundred patients with recurrent failed implantation were randomized into two groups. A total of 139 patients underwent ovarian stimulation, and preimplantation genetic screening was performed in 72 patients.

Intervention(s): Analysis of chromosomes X, Y, 13, 16, 18, 21 and 22 was carried out with the fluorescence in situ hybridization technique in a blastomere biopsied from day 3 embryos in the study group.

Main Outcome Measure(s): The primary endpoint is implantation rate. Secondary endpoints are embryo morphology and chromosomal status, number of transferred embryos and clinical pregnancy rate.

Result(s): There is no significant difference of the implantation rate between the study group (18.4%) and the control group (26.8%). The number of embryos replaced is significantly lower in the control group, namely 2.1 versus 1.4 in the control group.

Conclusion(s): Preimplantation genetic screening does not increase the implantation rates after IVF-ICSI in women with recurrent failed implantation.
- Main changes (audit trail)
- RECORD11-jun-2008 - 25-jul-2008


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl